Although Escherichia coli is the predominant aerobic organism of normal human fecal flora, there exist several pathogenic types (12) . These include enteroinvasive E. coli (EIEC) strains that have the ability to attach to, invade, multiply within, and destroy colonic epithelial cells (12) . The clinical manifestations of EIEC infections are similar to those caused by Shigella species, which are closely related to EIEC on a genetic level. In addition, the invasive potential of EIEC is associated with a plasmid which has significant sequence homology with the invasion plasmid of Shigella sp. (9, 16 ). Shigellemia has been described previously most commonly for malnourished infants, elderly persons, and other compromised hosts (10, 19) , including patients with AIDS (13) . Bacteremia caused by EIEC has not been described previously.
Diarrhea is a common problem in persons infected with the human immunodeficiency virus (HIV). The etiologic agent frequently cannot be identified, despite extensive investigation (18) . We report a case of recurrent diarrhea and bacteremia due to an enteroinvasive strain of E. coli.
A fermentation of gas from glucose, indole, and acetate were repeated by NCCLS recommended methods on the July blood isolate (strain 89-120). The isolate was examined for chromosomal DNA hybridization with DNA probes for EIEC, entero-effacing E. coli, and genes coding for Shiga-like toxin I and Shiga-like toxin Il as previously described (6) . Assays for production of heatlabile (15) and heat-stable (5) enterotoxin and the rabbit keratoconjunctivitis test (17, 22) were performed as previously described.
The E. coli isolate from the patient's blood in July 1989 (strain 89-120) was cultured for 18 h at 37°C on Trypticase soy agar with 5% sheep erythrocytes. Cells were washed twice in sterile distilled water and then diluted in medium 199 (4) (pH 7.4) to a final concentration of 105/ml. All sera were heated to 56°C for 30 min to inactivate HIV and then diluted in Hanks balanced salt solution. Because heating also inactivated complement, serum from a hypogammaglobulinemic patient was used as a standard complement source, as previously described (4) . To remove any cross-reacting antibodies, this serum was absorbed 10 times for 30 min each time at 0°C with E. coli 89-120. Susceptibility of the E. coli strain to bactericidal activity in the serum specimens from the affected patient and nine homosexual controls (four HIV infected and five HIV uninfected) was tested as previously described (4 C Absorbed hypogammaglobulinemic serum was added as a complement source to heat-inactivated control or patient serum, as described elsewhere (3). The dates for the patient samples refer to dates serum was obtained. (18) , but there was no identification of pathotypes. EIEC bacteremia has not been described previously, but it may occur sporadically in immunocompromised hosts and remain undiagnosed.
Most diarrheal illnesses of bacterial origin in normal hosts are self-limited, but in patients with AIDS recurrence of infection after a course of therapy is common (3, 14) . Similarly, this patient had recurrence of disease after each course of antibiotics until chronic suppressive therapy was begun. Bacteremia due to diarrheal pathogens is uncommon, occurring mostly at the extremes of age or in compromised hosts (19) . Bacteremia due to serum-sensitive organisms is uncommon except in immunocompromised individuals, such as our patient. Strain 89-120 was killed in vitro by pooled normal human serum and by sera from HIV-positive and HIV-negative homosexual controls but not by the patient's serum obtained prior to his illness nor by sera collected between episodes. The lack of bactericidal activity correlates with the patient's recurrent bacteremia. The demonstration of suppressive activity in the patient's serum in the presence of antimicrobial agents is consistent with the lack of further episodes of bacteremia after therapy was begun.
None of the HIV-positive controls met the case definition for AIDS and therefore, they are likely to have less severe immune deficiency than did the case patient. It is likely that our patient was not unique in his inability to control EIEC infection. Rather, he was a man with severe immune depletion due to HIV, who encountered a pathogen that is relatively uncommon in the United States. In the developing world, where EIEC is more prevalent (20) isolates were found to be lysine decarboxylase negative (21) whereas 75% of all other E. coli isolates were positive. In the appropriate clinical setting, E. coli isolates from blood cultures which are lysine decarboxylase negative should be suspected of being EIEC. In summary, we present a case of recurrent bacteremia due to EIEC in an immunocompromised man whose serum lacked the ability to kill the pathogen. Recognition of the pathophysiology of his recurrent bacteremias spared him further invasive evaluation for a more common anatomic source of E. coli bacteremia, such as biliary tract or urinary tract disease.
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